Search research articles
Contact Us
Filters
Showing results (31-40 of 57) with videos related to
Page
of 6
Sort By:
BMC Medicine
|
April 26, 2026
Personalizing the treatment of head and neck cancer in vitro: The 3D-OTC model
Fabian Stögbauer, Tobias Weiser, Ali Bashiri Dezfouli, et al.
Genes, Chromosomes & Cancer
|
June 23, 2017
Mutational profiles of Brenner tumors show distinctive features uncoupling urothelial carcinomas and ovarian carcinoma with transitional cell histology
Nicole Pfarr, Silvia Darb-Esfahani, Jonas Leichsenring, et al.
British Journal of Cancer
|
January 8, 2024
Correction: Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer
Fabian Stögbauer, Susanne Beck, Iordanis Ourailidis, et al.
British Journal of Cancer
|
April 12, 2023
Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer
Fabian Stögbauer, Susanne Beck, Iordanis Ourailidis, et al.
The Journal of Pathology. Clinical Research
|
September 16, 2022
Cellular dissociation grading on biopsies of pulmonary squamous cell carcinoma provides prognostic information across all stages and is congruent with resection specimen grading
Moritz Jesinghaus, Melanie Boxberg, Maxime Schmitt, et al.
Oncotarget
|
June 29, 2017
Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping
Moritz Jesinghaus, Katja Steiger, Julia Slotta-Huspenina, et al.
Cancer Immunology, Immunotherapy : CII
|
December 19, 2020
The immunologic tumor microenvironment in endometrioid endometrial cancer in the morphomolecular context: mutual correlations and prognostic impact depending on molecular alterations
Barbara Willvonseder, Fabian Stögbauer, Katja Steiger, et al.
The American Journal of Surgical Pathology
|
May 16, 2017
A Novel Grading System Based on Tumor Budding and Cell Nest Size Is a Strong Predictor of Patient Outcome in Esophageal Squamous Cell Carcinoma
Moritz Jesinghaus, Melanie Boxberg, Björn Konukiewitz, et al.
British Journal of Cancer
|
October 7, 2021
Loss of CDX2 in colorectal cancer is associated with histopathologic subtypes and microsatellite instability but is prognostically inferior to hematoxylin-eosin-based morphologic parameters from the WHO classification
Björn Konukiewitz, Maxime Schmitt, Miguel Silva, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 20, 2025
PET/CT imaging of esophageal cancer targeting tumor cell specific αvβ6-integrin expression
Kateřina Dvořáková Bendová, Tanja Groll, Barbora Neužilová, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 57) with videos related to
Sort By:
Page
of 6
BMC Medicine
|
April 26, 2026
Personalizing the treatment of head and neck cancer in vitro: The 3D-OTC model
Fabian Stögbauer, Tobias Weiser, Ali Bashiri Dezfouli, et al.
Genes, Chromosomes & Cancer
|
June 23, 2017
Mutational profiles of Brenner tumors show distinctive features uncoupling urothelial carcinomas and ovarian carcinoma with transitional cell histology
Nicole Pfarr, Silvia Darb-Esfahani, Jonas Leichsenring, et al.
British Journal of Cancer
|
January 8, 2024
Correction: Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer
Fabian Stögbauer, Susanne Beck, Iordanis Ourailidis, et al.
British Journal of Cancer
|
April 12, 2023
Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer
Fabian Stögbauer, Susanne Beck, Iordanis Ourailidis, et al.
The Journal of Pathology. Clinical Research
|
September 16, 2022
Cellular dissociation grading on biopsies of pulmonary squamous cell carcinoma provides prognostic information across all stages and is congruent with resection specimen grading
Moritz Jesinghaus, Melanie Boxberg, Maxime Schmitt, et al.
Oncotarget
|
June 29, 2017
Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping
Moritz Jesinghaus, Katja Steiger, Julia Slotta-Huspenina, et al.
Cancer Immunology, Immunotherapy : CII
|
December 19, 2020
The immunologic tumor microenvironment in endometrioid endometrial cancer in the morphomolecular context: mutual correlations and prognostic impact depending on molecular alterations
Barbara Willvonseder, Fabian Stögbauer, Katja Steiger, et al.
The American Journal of Surgical Pathology
|
May 16, 2017
A Novel Grading System Based on Tumor Budding and Cell Nest Size Is a Strong Predictor of Patient Outcome in Esophageal Squamous Cell Carcinoma
Moritz Jesinghaus, Melanie Boxberg, Björn Konukiewitz, et al.
British Journal of Cancer
|
October 7, 2021
Loss of CDX2 in colorectal cancer is associated with histopathologic subtypes and microsatellite instability but is prognostically inferior to hematoxylin-eosin-based morphologic parameters from the WHO classification
Björn Konukiewitz, Maxime Schmitt, Miguel Silva, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 20, 2025
PET/CT imaging of esophageal cancer targeting tumor cell specific αvβ6-integrin expression
Kateřina Dvořáková Bendová, Tanja Groll, Barbora Neužilová, et al.
Page
of 6